Use of the Heartmate 3 for biventricular support as a bridge to heart transplant-first US implant Article

Full Text via DOI: 10.1111/jocs.14290 PMID: 31609485 Web of Science: 000490360200001

Cited authors

  • Bansal, Aditya; Akhtar, Faisal; Zwintscher, Nathan P.; Ostrow, Sheila; Desai, Sapna; Fary, David


  • Right ventricular failure continues to be the Achilles heel in the management of heart failure patients. Traditionally, either high doses of inotropes and inhaled nitric oxide or jerry-rigged temporary mechanical devices have been used to support failing right ventricles. No durable implantable right ventricular assist device has been developed to address this long-standing concern. Because of this vacuum of innovation, surgeons have started using the third-generation LVADs to support the right ventricle. The HeartMate 3 (Abbott) LVAD is a safe and effective therapy for the management of biventricular failure.

Publication date

  • 2019

Published in

International Standard Serial Number (ISSN)

  • 0886-0440

Start page

  • 1629

End page

  • 1631


  • 34


  • 12